Fresenius Medical Care (FMS) reported Q4 non-IFRS earnings Tuesday of 1.44 euros ($1.70) per share, up from 0.91 euro a year earlier.
Analysts polled by FactSet expected 1.16 euros.
Revenue for the quarter ended Dec. 31 was 5.07 billion euros, down from 5.09 billion euros a year earlier.
Analysts surveyed by FactSet expected 4.85 billion euros.